AMENDMENT OF SECURITIES PURCHASE AGREEMENT AND SERIES B UNIT PURCHASE WARRANTSecurities Purchase Agreement • June 13th, 2008 • Cell Therapeutics Inc • Pharmaceutical preparations
Contract Type FiledJune 13th, 2008 Company IndustryThe Securities Purchase Agreement dated April 29, 2008 between Cell Therapeutics, Inc. (the “Company”) and BAM Opportunity Fund LP (the “Holder”) and the Series B Unit Purchase Warrant dated April 30, 2008 are hereby amended as follows, as of June 10, 2008.